RiverPark Advisors’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$426K Buy
17,887
+2,901
+19% +$55.7K 0.19% 67
2026
Q1
$264K Sell
14,986
-195
-1% -$3.92K 0.1% 80
2025
Q4
$300K Buy
15,181
+305
+2% +$5.48K 0.09% 81
2025
Q3
$260K Sell
14,876
-4,248
-22% -$63K 0.11% 65
2025
Q2
$268K Sell
19,124
-799
-4% -$12.9K 0.16% 65
2025
Q1
$371K Buy
19,923
+10,512
+112% +$157K 0.29% 58
2024
Q4
$106K Buy
+9,411
New +$110K 0.08% 99

Other funds holding ALHC

RiverPark Advisors's ALHC Position: Q2 2026 in Review

RiverPark Advisors increased its Alignment Healthcare (ALHC) stake by 19% in Q2 2026, buying an estimated $55.7K and bringing the position to 17,887 shares worth $426K. The position accounts for 0.19% of the portfolio, ranked #67.

RiverPark Advisors first reported a position in ALHC in Q4 2024 and has held it in 7 quarters since. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • RiverPark Advisors held 17,887 shares of Alignment Healthcare worth $426K as of Q2 2026.
  • RiverPark Advisors bought 2,901 Alignment Healthcare shares in Q2 2026, an estimated $55.7K.
  • Alignment Healthcare made up 0.19% of RiverPark Advisors's portfolio in Q2 2026, its #67 holding.
  • RiverPark Advisors first reported a position in Alignment Healthcare in Q4 2024 and has held it in 7 quarters since.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on RiverPark Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.